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The immune system responds vigorously to microbial infection while permitting lifelong colonization by the microbiome. Mechanisms that facilitate the establishment and stability of the gut microbiota remain poorly described. We found that a regulatory system in the prominent human commensal Bacteroides fragilis modulates its surface architecture to invite binding of immunoglobulin A (IgA) in mice. Specific immune recognition facilitated bacterial adherence to cultured intestinal epithelial cells and intimate association with the gut mucosal surface in vivo. The IgA response was required for B. fragilis (and other commensal species) to occupy a defined mucosal niche that mediates stable colonization of the gut through exclusion of exogenous competitors. Therefore, in addition to its role in pathogen clearance, we propose that IgA responses can be co-opted by the microbiome to engender robust host-microbial symbiosis.
A t birth, ecological and evolutionary processes commence to assemble a complex microbial consortium in the animal gut. Community composition of the adult human gut microbiome is remarkably stable during health, despite day-to-day variability in diet and diverse environmental exposures. Instability, or dysbiosis, may be involved in the etiology of a variety of immune, metabolic, and neurologic diseases (1, 2) . Longitudinal sequencing studies indicate that a majority of bacterial strains persist within an individual for years (3) , and for most species there is a single, persistently dominant strain (4) (termed "single-strain stability"). Mucus and components of the innate and adaptive immune systems are thought to influence microbiome stability, independently of diet. For example, immunoglobulin A (IgA), the main antibody isotype secreted in the gut, shapes the composition of the intestinal microbiome via currently unknown mechanisms (5) (6) (7) (8) . IgA deficiency in mice increases interindividual variability in the microbiome (9) and decreases diversity (10, 11) . The direct effects of IgA on bacteria have largely been studied in the context of enteric infection by pathogens (12) . However, early studies of IgA in the healthy gut found that the majority of live bacterial cells in feces are bound by IgA (13), reflecting a steady-state IgA response to persistent indigenous microbes (14) . Studies show that IgA promotes adherence of commensal bacteria to tissue-cultured intestinal epithelial cells (15, 16) , although the in vivo implications of this observation are unclear. Furthermore, lack of IgA, the most common human immunodeficiency, does not affect lifespan and only modestly increases susceptibility to respiratory and gastrointestinal infections (17) ; hence, it remains a mystery why the immune system evolved to invest the considerable energy needed to produce several grams of IgA daily (18) .
Bacteroides fragilis is an important member of the human gut microbiome, with beneficial properties that ameliorate inflammatory and behavioral symptoms in preclinical animal models (19) (20) (21) (22) . This commensal exhibits remarkable single-strain stability (23, 24) and enriched colonization of the gut mucosal surface relative to other species (25) . To explore physical features of B. fragilis interaction with the host epithelium, we used transmission electron microscopy (TEM) to visualize colonic tissues of monocolonized mice. B. fragilis commonly formed discrete aggregates of tightly packed cells on the apical epithelial surface (Fig. 1A) and penetrated the glycocalyx layer of transmembrane mucins, nearly contacting the microvilli (Fig. 1B and fig. S1 , A and B). Intact B. fragilis cells were also found nestled in the ducts of the crypts of Lieberkühn (Fig. 1C and fig. S1C ). We previously identified a genetic locus in B. fragilis, named the commensal colonization factors (ccfABCDE), which is necessary for colonization of colonic crypts (26) . To assess how these genes affect bacterial localization to the mucosal surface, we monocolonized mice with a ccfCDE (Dccf ) mutant. TEM showed that B. fragilis Dccf was found only as sparse, individual cells within the epithelial mucosa, excluded from contact with the glycocalyx (Fig. 1, D and E) ; unlike wild-type B. fragilis, it was never observed in aggregates (Fig. 1F) . The B. fragilis burden in the colon lumen was identical between strains ( fig. S2A ), which suggests that the CCF system is required specifically for bacterial aggregation within mucus.
High-resolution tomograms of bacterial cells in vivo revealed the presence of a thick, fuzzy capsule layer covering wild-type B. fragilis (Fig. 1G) , which was significantly reduced in B. fragilis Dccf (Fig. 1, H and I) . We sought to investigate the bacterial physiology underlying this ultrastructural change and its potential corresponding effects on colonization. The ccf locus is highly induced during gut colonization (26) and bacterial growth in mucin O-glycans (27) , indicating that the CCF system may sense a specific hostderived glycan. The ccf genes are homologous to polysaccharide utilization systems in which a sigma factor (ccfA) is activated by extracellular glycan sensing (28) ; thus, we hypothesized that ccfA may activate genes involved in mucosal colonization. We overexpressed ccfA in B. fragilis and assessed global gene expression by RNA sequencing (RNA-seq) during in vitro growth [without overexpression, ccf is poorly expressed in culture (26)]. Of the non-ccf genes regulated by ccfA, 24 of 25 genes mapped to the biosynthesis loci for capsular polysaccharides A and C (PSA and PSC) (Fig. 2, A and B, and table S1). Correspondingly, ccf mutation decreased expression of PSC and increased expression of PSA in vivo (Fig. 2C) . Although phase variation of capsular polysaccharides is known to influence the general in vivo fitness of B. fragilis (29, 30) , these studies identify a pathway for transcriptional regulation of specific polysaccharides in the context of mucosal colonization.
We modeled single-strain stability using a horizontal transmission assay, wherein co-housing animals respectively harboring isogenic strains of wild-type B. fragilis resulted in minimal strain transmission from one animal to another (Fig. 2D  and fig. S2A ). This intraspecies colonization resistance is provided through bacterial occupation of a species-specific nutrient or spatial niche (26) . However, as previously reported (26) , when mice were colonized initially with B. fragilis Dccf, animals were permissive to co-colonization by wildtype B. fragilis after co-housing ( Fig. 2E and  fig. S2B ), indicating a CCF-dependent defect in niche saturation. Mice harboring a mutant in the biosynthesis genes for PSC (DPSC) showed highly variable co-colonization by wild-type bacteria ( Fig. 2F and fig. S2C ). We observed an unexpected increase in expression of the PSB biosynthesis genes in this mutant (Fig. 2H) , which may compensate for the loss of PSC.
We generated a strain defective in synthesizing both PSB and PSC (DPSB/C), and mice mono-associated with the double mutant were consistently unable to maintain colonization resistance ( Fig. 2G and fig. S2 , D to F), even though the strain retained ccf expression ( fig. S2G ). Despite lack of competition in a monocolonized setting and equal levels of colonization in the colon lumen ( fig. S2H ), the B. fragilis Dccf and DPSB/C strains were defective in colonization of the ascending colon mucus (Fig. 2I) , reflecting impaired saturation of the mucosal niche.
Accordingly, when we used TEM to image the DPSB/C strain in vivo, although the capsule was not as thin as in B. fragilis Dccf (fig. S2, I and J), the hallmark epithelial aggregation phenotype was abrogated relative to wild-type bacteria (fig. S2, K and L). Therefore, we conclude that the CCF system regulates capsule expression to mediate B. fragilis mucosal colonization and single-strain stability.
To investigate host responses contributing to mucosal colonization, we defined the transcriptome of the ascending colon during colonization with wild-type B. fragilis or B. fragilis Dccf. Remarkably, 7 of the 14 differentially expressed genes encoded Ig variable chains ( are not caused by inflammation. Accordingly, we tested whether capsular polysaccharide regulation by ccf affects IgA recognition of bacteria (31) (32) (33) . In fecal samples from monocolonized animals, wildtype B. fragilis was highly coated with IgA, which was significantly diminished in Dccf and DPSB/C strains (Fig. 3 , B and C, and fig. S4A ). We observed no difference between these strains in the induction of total fecal IgA (Fig. 3D) , reflecting equivalent stimulation of nonspecific IgA production (10, 34, 35) . To test bacteria-specific responses, we evaluated IgA that had been extracted from feces of mice monocolonized with B. fragilis for binding to bacteria recovered from monocolonized Rag1 −/− mice (in vivo-adapted, yet IgA-free bacteria). Western blots of bacterial lysates showed that strong IgA reactivity to capsular polysaccharides was abrogated in the Dccf and DPSB/C strains (Fig. 3, E and F) . Although IgA can be polyreactive (10, 34, 35) , binding to lysates of Bacteroides was species-specific ( fig. S4B ) and required induction of IgA after bacterial colonization ( fig. S4, C and D) . Accordingly, in a wholebacteria binding assay, IgA induced by wild-type bacteria maximally coated wild-type B. fragilis, unlike the Dccf and DPSB/C strains (Fig. 3G) . IgA induced by B. fragilis Dccf exhibited reduced binding to wild-type bacteria (Fig. 3G) . The addition of IgA to in vivo-adapted, IgA-free bacteria increased adherence of B. fragilis to intestinal epithelial cells in tissue culture (Fig. 3H ), yet had no effect on bacterial viability ( fig. S4E ). Cell lines known to produce more mucus (36) exhibited a greater capacity for IgA-enhanced B. fragilis adherence ( fig. S4F ), consistent with prior work showing that IgA binds mucus (36) (37) (38) . IgA-enhanced adherence was decreased whether targeted bacteria lacked ccf or PSB/C, or whether the IgA tested was induced by a ccf mutant or by B. thetaiotaomicron (Fig. 3H and fig. S4G ). Whereas pathogenic bacteria elaborate capsular polysaccharides for immune evasion, these results suggest that B. fragilis deploys specific capsules for immune attraction, potentially enabling stable mucosal colonization.
We determined whether IgA coating promotes B. fragilis colonization in mice. Under the horizontal transmission paradigm, Rag1 −/− mice colonized with wild-type B. fragilis were readily co-colonized by an isogenic strain from a cohoused animal ( fig. S5, A and B) , showing loss of colonization resistance in the absence of adaptive immunity. We next treated wild-type mice with an antibody to CD20 ( fig. S5C) (39) to deplete B  cells (fig. S5, D to F) , thus reducing total fecal IgA levels ( fig. S5G ) and eliminating IgA coating of wild-type B. fragilis during monocolonization (Fig. 4A) . IgA recovered from isotype controltreated mice that had been monocolonized with B. fragilis promoted adherence of wild-type bacteria to epithelial cells in vitro, whereas IgA from anti-CD20-treated mice had no effect despite being exposed to B. fragilis antigens (Fig. 4B) . In the horizontal transmission assay, B celldepleted mice monocolonized with B. fragilis were readily invaded by wild-type bacteria, whereas isotype control-injected animals retained colonization resistance (Fig. 4C and fig. S5H ). Therefore, active B cell responses to B. fragilis colonization enhance single-strain stability.
Because B cell depletion eliminates all antibody isotypes, germ-free IgA −/− mice (40) were generated and monocolonized with B. fragilis. We did not observe compensatory coating by IgM ( fig. S6A) . In a horizontal transmission assay with wild-type (BALB/c) and IgA −/− mice, lack of IgA allowed co-colonization by challenge strains (Fig. 4D and fig. S6 , B to D), indicating that IgA specifically contributes to single-strain stability. This feature was reproduced in mice with a full microbial community "spiked" with genetically marked B. fragilis strains (fig. S6, E and F WT PSB/C *** *** *** revealing that single-strain stability of an individual bacterial species occurs in the context of a complex community. Monocolonized IgA −/− mice harbored reduced levels of live bacteria in the colon mucus relative to wild-type mice (Fig. 4E) , although they had greater numbers of bacteria in the colon lumen ( fig. S6G ). TEM images of ascending colon tissues reveal that in IgA −/− animals, wild-type B. fragilis failed to aggregate on the epithelial surface (Fig. 4, F and  G) , similar to the ccf and PSB/C mutants in wildtype animals. B. fragilis cells also formed aggregates in feces in the presence of IgA ( fig. S7 ), indicating that enhanced mucosal colonization may be due to increased aggregation or growth (41) within mucus. These findings converge to support a model whereby ccf regulates expression of specific capsular polysaccharides to attract IgA binding, allowing for robust mucosal colonization and single-strain stability.
Beyond B. fragilis, we tested whether IgA shapes a complex microbiome after controlled introduction of mouse microbiota to germ-free BALB/c or IgA −/− mice. One month after colonization, despite similar microbiome profiles in feces of both mouse genotypes ( fig. S8A) , we observed differences for specific taxa (table S3) . We also identified a defect in community stratification between the colonic mucus and lumen of IgA −/− mice ( Fig. 4H and fig. S8B ); this result indicates that IgA is required to individualize microbiome profiles between these two anatomic locations. Remarkably, a highly mucus-enriched exact sequence variant, mapping uniquely to B. fragilis, was significantly decreased in the mucus of IgA −/− mice relative to BALB/c mice ( Fig. 4I and fig. S9A ), naturally supporting our observations from monocolonized mice. To extend this analysis to other microbial species, we identified Rikenellaceae, Blautia sp., and segmented filamentous bacteria as being highly IgA-coated ( fig. S9B) (35) , and we assessed the abundance of these taxa in the colonic or ileal mucus. Blautia sp. and segmented filamentous bacteria displayed increased mucosal association in the absence of IgA (Fig. 4I) (42) , demonstrating that IgA can protect the intestinal barrier. However, similar to B. fragilis, Rikenellaceae were highly abundant in colon mucus and were significantly depleted in IgA −/− mice (Fig. 4I) . We conclude that IgA-enhanced mucosal colonization occurs within complex communities for multiple strains of B. fragilis and other species of the gut microbiome.
Classically viewed, the immune system evolved to prevent microbial colonization. However, our findings show that animals tolerate a complex microbiome; moreover, in the case of B. fragilis, its intimate association with its mammalian host is (paradoxically) enabled when an immune response is provoked. Related commensal bacteria may also benefit from actively engaging IgA during symbiosis, as Rag2 −/− mice devoid of adaptive immunity harbor fewer Bacteroides (43) and both B cell-deficient and IgA −/− animals display decreased colonization by the Bacteroidaceae family (44) . IgA has been previously shown to increase adherence of Escherichia coli (15), Bifidobacterium lactis, and Lactobacillus rhamnosus (16) to tissuecultured epithelial cells, which suggests that these microorganisms may also benefit from IgA to establish a mucosal bacterial community.
Mucosal microbiome instability or loss of immunomodulatory species may underlie the link between IgA deficiency and autoimmune diseases in humans (45) . Whereas IgA-coated bacteria from individuals with inflammatory bowel disease (46) or nutritional deficiencies (47) pathologies in mice, IgA-coated bacteria from healthy humans protect mice from disease (47) . We propose that during health, IgA fosters mucosal colonization of microbiota with beneficial properties (9), whereas disease states may induce (or be caused by) IgA responses to pathogens or pathobionts that disrupt healthy microbiome equilibria. Indeed, computational models indicate that IgA can both maintain indigenous mucosal populations and clear invasive pathogens (48) . In addition to serving as a defense system, adaptive immunity apparently evolved to engender intimate association with members of the gut microbiome.
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